Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Cytopenia × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1 Classical hematology 1

Conditions

Motor Activity 28 Neoplasms 13 Breast Neoplasms 12 Lymphoma 5 Sarcopenia 3 Prostatic Neoplasms 3 Polycystic Ovary Syndrome 3 Fatigue 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Obesity 2 Malnutrition 2 Lung Neoplasms 2 Insulin Resistance 2 Hematologic Neoplasms 2 Head and Neck Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Cardiovascular Diseases 2 Cardiotoxicity 2 Carcinoma, Non-Small-Cell Lung 2 Weight Cycling 1 Waldenstrom Macroglobulinemia 1 Uveal Melanoma 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Testicular Neoplasms 1 Recurrence 1

Interventions

thymoglobulin 1 fludarabine phosphate 1 fludarabine 1 decitabine and cedazuridine drug combination 1 Specimen Handling 1 Pluvicto 1 Peripheral Blood Stem Cell Transplantation 1 Metformin 1 Immunotherapy, Adoptive 1 Granulocyte Colony-Stimulating Factor 1 Genetic Counseling 1 Filgrastim 1 Exercise 1 Emapalumab 1 Cyclophosphamide 1 Busulfan 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06773871 2025-08-19

HemEx

Rigshospitalet, Denmark

Phase NA Recruiting

Classical hematologyMyeloid

Cytopenia, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡